Cytarabine and highly active antiretroviral therapy in HIV-related progressive multifocal leukoencephalopathy

被引：0

作者：

R. H. Enting

P. Portegies

机构：

[1] Department of Neurology,

[2] Academic Medical Center H2-214,undefined

[3] Meibergdreef 9,undefined

[4] 1105 AZ,undefined

[5] Amsterdam,undefined

[6] The Netherlands e-mail: P.Portegies@amc.uva.nl Tel.: +31-20-5663842 Fax: +31-20-6971438,undefined

来源：

Journal of Neurology | 2000年 / 247卷

关键词：

Key words Progressive multifocal leukoencephalopathy; Anti-HIV agents; Cytarabine; HIV infection;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

We assessed survival in AIDS-related progressive multifocal leukoencephalopathy (PML) and the effect of cytarabine and antiretroviral therapy in a retrospective analysis of a series of consecutive 35 patients with AIDS-related PML in an academic AIDS referral center over ¶15 years. Treatment regimens consisted of highly active antiretroviral treatment (HAART), intravenous cytarabine, or both. Median survival after diagnosis in the overall series was 88 days. Patients with low CD4 cell count tended to have shorter survival. Seven patients (20%) had prolonged survival (> 1 year). Cytarabine did not affect survival. Seven patients were treated with HAART, which did not significantly improve survival. We conclude that the prognosis of AIDS-related PML is still poor, with a median survival of ¶3 months.

引用

页码：134 / 138

页数：4

共 50 条

[21] The prognosis of highly active antiretroviral therapy (HAART) treated HIV infected patients in Serbia, related to the time of treatment initiation
Jevtovic, Dj.
Salemovic, D.
Ranin, J.
Dulovic, O.
Ilic, D.
Brmbolic, B.
JOURNAL OF CLINICAL VIROLOGY, 2010, 47 (02) : 131 - 135
[22] Features of kidney affection in the conditions of highly active antiretroviral therapy in patients with HIV/AIDS
Ryabokon, E. V.
Onishchenko, T. E.
Koltunik, E. L.
PATHOLOGIA, 2013, (02): : 85 - 87
[23] Incidence of pneumonia in HIV-infected patients in the highly active antiretroviral therapy era
Velasco Arribas, Maria
Satue Bartolome, Jose Angel
Losa Garcia, Juan Emilio
Espinosa Gimeno, Alfredo
Delgado-Iribarren, Alberto
Castilla Castellano, Virgilio
MEDICINA CLINICA, 2007, 128 (04): : 130 - 132
[24] Effect of Simultaneous Use of Highly Active Antiretroviral Therapy on Survival of HIV Patients With Tuberculosis
Velasco, Maria
Castilla, Virgilio
Sanz, Jose
Gaspar, Gabriel
Condes, Emilia
Barros, Carlos
Cervero, Miguel
Torres, Rafael
Guijarro, Carlos
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (02) : 148 - 152
[25] Disease-Modifying Therapeutic Concepts for HIV in the Era of Highly Active Antiretroviral Therapy
Butler, Scott L.
Valdez, Hernan
Westby, Michael
Perros, Manos
June, Carl H.
Jacobson, Jeffrey M.
Levy, Yves
Cooper, David A.
Douek, Daniel
Lederman, Michael M.
Tebas, Pablo
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 58 (03) : 297 - 303
[26] Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients
de Olalla, PG
Knobel, H
Carmona, A
Guelar, A
López-Colomés, JL
Caylà, JA
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 30 (01) : 105 - 110
[27] Sexual dysfunction in HIV-infected patients treated with highly active antiretroviral therapy
Collazos, J
Martínez, E
Mayo, J
Ibarra, S
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (03) : 322 - 326
[28] Caring for HIV-Infected Patients in the ICU in The Highly Active Antiretroviral Therapy Era
Corona, Alberto
Raimondi, Ferdinando
CURRENT HIV RESEARCH, 2009, 7 (06) : 569 - 579
[29] Possible association of sialolithiasis with HIV infection and highly active antiretroviral therapy: A case report
Brooks, John K.
Jones, Joyce L.
Price, Jeffery B.
SPECIAL CARE IN DENTISTRY, 2020, 40 (03) : 298 - 302
[30] Progressive multifocal leukoencephalopathy despite immune recovery in a HIV/HCV co-infected patient
Hentzien, M.
Guihot, A.
de Maindreville, Doe
Tabary, T.
Brodard, V.
Vieillard, V.
Adle-Biassette, H.
Bani-Sadr, F.
JOURNAL OF NEUROVIROLOGY, 2020, 26 (04) : 607 - 610

← 1 2 3 4 5 →